Quick answers
- What is Actoplus Met?
- Actoplus Met is a brand name of Pioglitazone and metformin hydrochloride, a prescription medicine. The FDA NDC Directory lists 1 Actoplus Met product in 1 strength and form.
- Who makes Actoplus Met?
- Takeda Pharms USA holds the FDA application for Actoplus Met (NDA021842, approved August 29, 2005).
- Is there a generic or store brand of Actoplus Met?
- Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Actoplus Met product, 2 of them generic. Ask your pharmacist whether one is right for you.
- Has Actoplus Met been recalled?
- No recall linked to Actoplus Met products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Actoplus Met is
Each Actoplus Met product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Pioglitazone and metformin hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| metformin hydrochloride 850 mg · pioglitazone hydrochloride 15 mg tablet, film coated (oral) | Actoplus Met | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Pioglitazone and metformin hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021842 | Takeda Pharms USA | August 29, 2005 | 1 |
Companies that list Actoplus Met
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Actoplus Met products.
- Takeda Pharmaceuticals America, Inc.1 product
Recalls
No recall linked to Actoplus Met products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.